Government's Central Drug Laboratory (CDL) which conducted quality tests on the samples lifted from Maiden pharmaceuticals - the Sonepat-based company which has been in the dock for allegedly causing deaths of children in Gambia - has found the products to be complying with specifications, putting the onus on World Health Organisation (WHO) for "prematurely" blaming an Indian company for the deaths without any "independent verification".
No comments:
Post a Comment